Skip to content

SI-BONE, Inc. SIBN Unrealized Losses on Investments (Before Tax)

Unrealized Losses on Investments (Before Tax) at other companies

Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$52.6M+11.2%
Gross profit$41.9M+11.3%
Operating income-$5.1M+31.9%
Net income-$4.3M+33.8%
EPS (diluted)-$0.10+33.3%

Balance sheet

See full
Cash & equivalents$33.5M-18.6%
Total debt$42.9M+15.6%
Total equity$178.9M+7.0%
Total assets$242.7M+6.8%

Cash flow

See full
Operating cash flow-$2.4M+51.9%
CapEx$1.1M-48.0%
Free cash flow-$3.4M+50.8%

Valuation

See full
Market cap$743.29M+6.4%
Enterprise value$752.71M+8.4%
P/S3.6×-0.4×

Profitability

See full
Gross margin79.6%+0.3pp
Operating margin-9.7%-3.0pp
Net margin-8.1%-2.6pp
FCF margin-2.9%-1.2pp

Returns & leverage

See full
Return on equity-9.6%-2.7pp
Debt / equity0.2×0.0×
Current ratio10×+1.5×

Where this comes from

Reported directly by SI-BONE, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.

The official record: SI-BONE, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about SI-BONE, Inc.'s unrealized losses on investments (before tax).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SI-BONE, Inc.'s unrealized losses on investments (before tax)?
SI-BONE, Inc. (SIBN) reported unrealized losses on investments (before tax) of $58K in Q1 2026.
How has SI-BONE, Inc.'s unrealized losses on investments (before tax) changed year-over-year?
SI-BONE, Inc.'s unrealized losses on investments (before tax) increased by 866.7% year-over-year, from $6K to $58K.
What is the long-term trend for SI-BONE, Inc.'s unrealized losses on investments (before tax)?
Over 4 years (2021 to 2025), SI-BONE, Inc.'s unrealized losses on investments (before tax) has grown at a -100.0% compound annual growth rate (CAGR), from $39K to $0.